中国首家！国产凝结魏茨曼氏菌，拿到FDA-GRAS认证

Core Viewpoint - The company Enkang Biotechnology, a subsidiary of Beijiajie, has received FDA-GRAS certification for its probiotic strain BC01, marking it as the first Chinese company to achieve this certification with the Weizmannia coagulans strain, which is considered a significant milestone in food safety standards [1][2]. Company Overview - Beijiajie primarily engages in the research, development, production, and sales of oral hygiene products, disposable sanitary products, and probiotic products, including probiotic raw materials and consumer products [2]. - Enkang has established two research centers in Suzhou and XuZhou, employing over 40 professionals with master's and doctoral degrees, and has developed a proprietary strain library with over 12,000 strains [3]. Product and Market Potential - The BC01 strain has been authorized with 8 domestic and international patents and has undergone 4 human clinical studies, targeting health issues such as constipation, immune enhancement, micro-ecological regulation, lipid metabolism improvement, and anti-aging [2][3]. - The probiotic can be utilized in various functional food products, beverages, gummies, and snacks, aligning with the growing demand in the health food market [2]. Financial Performance - In the first half of 2025, Beijiajie reported a revenue of 717 million yuan, a year-on-year increase of 15.64%, and a net profit attributable to shareholders of 43.52 million yuan, reflecting a growth of 31.31% [2].